Super Religare Laboratories
Limited (Formerly SRL Ranbaxy Ltd.) is the largest and most trusted
pathology laboratory network in India, servicing nearly 4,000 hospitals/path labs and
over 50,000 doctors. SRL performs over 34000 tests/day and caters to approximately 8 million
patients in a year offering a comprehensive range of over 3,500 tests, from the
routine to the highly specialized tests. The tests are based on more than 200 technologies
covering most known diseases.
Super Religare Laboratories Limited (Formerly SRL Ranbaxy Ltd.) intends to establish
its physical presence in Europe, the Middle East and South East Asia by setting
up Reference Laboratories, one in each area, in order to cater to the specialized
test requirements of the countries in these regions. It also wishes to expand its
operations to the countries in Africa and North America in order to tap the out
sourcing opportunities in these continents.
Super Religare Laboratories Limited (Formerly SRL Ranbaxy Ltd.) strives to strengthen
its analytical capability and take its services beyond providing just an inert report
by taking following steps: developing predictive and preventive capabilities; providing
advanced analytical support for better health management; taking Wellness beyond
physical health by focusing on lifestyle value adds such as emotional wellbeing.
Clinical Research Services Division is dedicated to offering Central Laboratory
Services to support the needs of drug development for various Phases of Clinical
Trials. It's a force offering Central Laboratory Services with an uniquely flexible
approach in customizing our services to comply with the protocol requirements and
the needs of our Sponsors with a commitment of accuracy and reproducibility of our
analytical data.
New tests and technologies offer advantage either in terms of Sensitivity, Specificity, Rapidity or Cost as compared to the available options. Considering the benefits and impact of these new developments in the patient care, we identify, innovate, develop and implement new tests and technologies to significantly address the unmet medical needs and enhance and extend human life. During the last few years more than “100” different new products pertaining to the diagnosis and management of Infectious diseases, Cancer, Metabolic diseases, Endocrine disorders etc. have been developed and successfully released.
Received Frost & Sullivan Award in 2007 and 2009 in the recognition of being the Diagnostics Company for the respective years.
•
The only Path lab network in the country to have 5 Clinical Reference Lab set-ups, nearly 50 Satellite labs and over 1000 Collection Centres across 450 towns.
•
Serving over 8 million customers per year and counting...
